Navigation Links
Hemostemix Hosts Cell Therapy Industry Seminar
Date:10/30/2013

Toronto, Canada & Kyriat Weizmann, Israel (PRWEB) October 31, 2013

Hemostemix Ltd. and BioForum have announced a jointly-sponsored symposium entitled “Cell Therapy – an evolving industry” to be held November 4 at the Dan Hotel in Tel Aviv, Israel.

The event will feature invited speakers including Dr. Elmar Burchardt, Pfizer’s Vice President of Regenerative Medicine and cell therapy executives from Canada, United States, India, and Israel. The seminar will brief attendees on global industry trends, discuss optimal cell therapy product development, review the impact of CROs on clinical trial outcomes, present key elements of cellular product analytics, outline cell therapy business models, and engage in an open dialogue about the potential keys to cell therapy being a pillar of future healthcare.

“We are pleased to play a role in hosting an event which highlights the global cell therapy industry,” stated Hemostemix President and founder, Dr. Valentin Fulga. “With this seminar, and others planned, we want to facilitate an information-exchange and dialogue between investors, clinicians, and scientists that will promote a greater understanding of how cell therapies will shape the future of medicine.”

“Bioforum is excited to provide what it believes will be an important and useful seminar in this exciting new field of science and medicine,” stated Yehudith Wexler, Chairperson of Bioforum.
For more information about the seminar, click here.

This seminar is part of a series of presentations intended to introduce the company and its platform technology to a wide audience in the context of the cell therapy industry’s progress and maturation. This includes a recent keynote presentation (“Synergetic Cell Population – a powerful tool for autologous therapies”) delivered October 23rd in Orlando, FL and an upcoming presentation (“A peripheral blood-derived cellular population can be differentiated into neural like progenitor cells”) at the TERMIS-AM 2013 Conference to be held November 10-13in Atlanta, Georgia.

About Hemostemix Ltd

Hemostemix Ltd is a Canadian-Israeli company developing and commercializing innovative blood-derived cell therapies for medical conditions not adequately addressed by current treatments with an operating research, development and manufacturing facility in Kiryat Weizmann Science Park, Ness Ziona. For more information see http://www.hemostemix.com.

About Bioforum

Established in 1998, Bioforum provides a wide range of services in the areas of Education and Training, Clinical Data, Regulatory Submissions and Clinical Supply (inPACK). Bioforum's strategic lines of business combine professional services, process optimization, technology and education. Bioforum maximizes their costumers’ benefits by providing cost effective outsourcing and consultation services for the pharmaceutical, medical and medical device industries. For more information about Bioforum, see http://www.bioforum.co.il.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11280279.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Hemostemix Announces Formation of Scientific Advisory Board
2. Hemostemix Announces US Patent Allowance
3. The Hemostemix Group of Companies Provides Corporate Strategy Update
4. Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
5. DTx Hosts Webinar on New Intel® Haswell Platform
6. Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013
7. Industry Leader Linguamatics Hosts Record-breaking Spring Users Conference in Cambridge, UK
8. Cambridge College School of Management Program Hosts a Panel Discussion On Trends and Opportunities In Health Information Technology
9. San Diego State University Hosts Open House for Life Science Immersion Biotechnology Program
10. Ultra Light Startups Hosts Future Energy Investor Feedback Forum at MIT
11. Bayer CropScience Hosts Third Sustainability in Agriculture: A Bayer Executive Course
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
(Date:6/23/2016)... Pleasant Prairie, WI (PRWEB) , ... June 23, ... ... sciences consultancy focused on quality, regulatory and technical consulting, provides a free ... webinar is presented on July 13, 2016 at 12pm CT at no charge. ...
Breaking Biology Technology:
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):